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Background & aims: Changes in the EU regulation on food for speciﬁc groups (FSG) [1] and within the
German social law [2] combined with various deﬁnitions in the legal and the scientiﬁc background led to
the need for development of a categorization system for “Food for special medical purposes” (FSMP) for
enteral use [3].
Methods: The system was developed by an interdisciplinary working group of two German industry
associations, which represent the leading manufacturers and distributors of FSMP in Europe. It aims to
minimize the misunderstandings surrounding the different deﬁnitions used in relation to enteral
nutritional products and incorporate the latest scientiﬁc knowledge and medical guidelines [4].
Results: The new proposal consists of a table which shows the product categories and brieﬂy the deﬁ-
nitions of the used terms. The text contains the relevant deﬁnitions of terms often used within the ﬁeld
of enteral nutrition.
Conclusion: This provides health care professionals with support and the decision making process for
the prescription and use of such products. Additionally it also beneﬁts the responsible authorities to
formulate new directives, which are user-friendly and reﬂect the latest knowledge in medical
nutrition.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of European Society for Clinical Nutrition and
Metabolism. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
In international publications on enteral nutrition, terms such as
“oral nutritional supplements (ONS)”/“sip-feeding” or “tube-
feeding” are used to describe the different routes of administration
[5,6]. The variation of such terms may lead to different in-
terpretations. Thus for more precise legal and regulatory [7,8]
purposes a more clear classiﬁcation is needed for these products.m, di.stippler@nefkom.net
Ltd. on behalf of European Society
y-nc-nd/4.0/).The demand for such a classiﬁcation was initiated by discussions
between the industry associations and the regulatory bodies with
the overall intention to ensure it is easy to interpret and be trans-
ferable into practice.
The German industry associations which represent the manu-
facturers and distributors of FSMP for enteral nutrition took on-
board this responsibility and developed a proposal of a new
categorization system. It reﬂects legal and regulatory requirements
[1,2], scientiﬁc and medical guidelines [4] and routes of adminis-
tration of enteral nutrition. The system was introduced to the
German Society of medical nutrition and it was published in Ger-
many in 2011 [3]. At the ESPEN congress 2013 the system was
presented to an international audience.for Clinical Nutrition and Metabolism. This is an open access article under the CC BY-
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The two German industrial associations Federal Association of
Producers of Food for Special Dietary Purposes (“Verband der Hers-
teller von Lebensmitteln für besondere Ern€ahrung¼ Di€atverband”)1
and German Medical Technology Association (“Bundesverband
Medizintechnologie ¼ BVMed”)2 established an interdisciplinary
working group to develop a new categorization system. The group
consisted of medical, scientiﬁc, legal and regulatory specialists. After
severalmeetings the systemwas ﬁnalized and agreed in a consensus
meeting.
This system consists of a table for a quick but detailed overview
of the different categories of enteral products supplemented by a
brief deﬁnition of each category. The intended dietary use of the
speciﬁc products is also included.
Finally an abbreviation table is included detailing all the com-
mon terms used in the area of enteral nutritional therapy. Such
terms are commonly used but rarely deﬁned, are precisely speciﬁed
in this document, incorporating the technical, legal and regulatory
requirements. This allows products to be easily identiﬁed and
classiﬁed (Table 1).
2.1. Goals of medical, enteral nutrition
The need and the beneﬁt of enteral nutrition is widely accepted
[9,10]. Enteral nutrition may be used as a replacement of normal
nutrition if this is not feasible (caused by e.g. swallowing disorders,
persistent vegetative state). Alternatively, it can be used to sup-
plement normal nutrition if this is not sufﬁcient enough (e.g. dis-
ease related weight loss and/or malnutrition, cachexia, metabolic
disorders).
The aim of enteral nutrition is either to improve or to sustain the
nutritional status of the patient.
The composition of any FSMP product for enteral nutrition is
based on international and national legal and regulatory codes
[8,11,12,13] and can be adapted to deﬁned diseases or disorders. For
such diseases the proportion of macronutrients and special in-
gredients has to be adopted (e.g. MCT fats for patients suffering
from digestion disorders for fatty acids, special micronutrient
composition for patients suffering from renal insufﬁciency).
Special enteral nutrition products are dedicated to the dietary
management of rare inborn or pediatric metabolic diseases. These
diseases/illnesses lead to severe mental and/or physical distur-
bances without dietary treatment. Treatment with adequate
products is a mandatory part of medical intervention.
In few cases enteral nutrition is used beyond the dietary man-
agement for the treatment of the underlying disease. An example is,
the use of enteral nutrition in pediatric patients suffering from
Crohn's disease. In this speciﬁc case, enteral nutrition is recom-
mended as the ﬁrst line therapy to induce remission [14,17].
2.2. Deﬁnitions
For a better understanding the following explanations and def-
initions of relevant terms are used with FSMP for enteral nutrition.
2.2.1. Balanced diets for enteral nutrition
Balanced diets for enteral nutrition are food for special medical
purposes, complying with the legal deﬁnition and requirements for1 Industry association which represents the manufacturers of special nutrition
located in Bonn.
2 Industry association which represents the manufacturers and distributors of
medical devices located in Berlin.FSMP products [8,11]. Theymust comply with the current European
and national legislation. This includes that the composition of
macro- and micronutrients reﬂects their intended dietetic use.
These products consist of proteins/peptides/amino acids, car-
bohydrates and/or fats, minerals, trace elements and vitamins. The
contents of micronutrients (minerals, trace elements and vitamins)
are deﬁned by EU directives [18, pp. 5e8], which clearly claim the
minimum and maximum content of these micronutrients for fully
balanced products. For products which are not fully balanced, only
the maximum contents are deﬁned. These speciﬁc requirements
are the same all over the EU and so the same products can be used
in all these countries.
The composition of macronutrients is not strictly deﬁned. But a
product intended to be fully balanced and as a sole source of
nutrition must provide at least an adequate amount of essential
macronutrients (proteins/peptides/amino acids, essential fatty
acids) to meet patient needs. This leads to a composition of approx.
8e30 percent of energy by proteins, approx. 25e40 percent of
energy by fat and approx. 30e65 percent of energy by carbohy-
drates (including ﬁbers).
The products can be used for complete (2.1.1) or supplementary
(2.1.2) nutrition and are either balanced completely (2.1.3) or sup-
plementary (2.1.4).
They are intended for a therapeutic dietary treatment (2.2) for
patients suffering from
 a limited or disturbed or missing ability of ingesting, digesting,
metabolizing or segregating of normal food
OR
 other medically based nutritional needs for a dietary treatment
which exceeds modiﬁcation of normal nutrition or other dietary
food or a combination of both.
The intention of balanced diets for enteral nutrition is not to
show pharmaceutical effects as occur with pharmaceutical prod-
ucts. They are also not food supplements and their content reﬂects
the state of the scientiﬁc and technical knowledge and these are
formulated for patients.
2.2.1.1. Products for complete nutrition. A product which is appro-
priate for complete nutrition needs to be fully balanced. This means
the composition of such a product contains all macro- and micro-
nutrients that are needed to cover the nutritional needs and is
suitable to be used as a sole source of nourishment.
2.2.1.2. Products for supplementary nutrition. A balanced diet for
supplementary use is intended to be used in combination with
other foods and/or forms of nutrition (e.g. normal nutrition or
parenteral nutrition). Therefore fully balanced as well as incom-
plete balanced products can be used [18]. They contain relevant
amounts of macro- and micronutrients, which are appropriate for
the supplementary nutritional intervention.
2.2.1.3. Completely (fully) balanced diets (nutritionally complete).
A completely (fully) balanced diet is a product which fulﬁlls the
requirements of the EU directive for all nutrients mentioned there
[18]. If used according to the recommendations of themanufacturer
it can be the sole source of nutrition for the intended patients.
2.2.1.4. Supplementary balanced diets (nutritionally incomplete).
A supplementary balanced diet is a dietary product which is not
intended for use as a sole source of nutrition according to the EU
directive.
Table 1
Product categories for enteral nutrition e overview of their new categorization.
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trients in a higher concentration and which are therefore not
appropriate to be a sole source of nutrition.
2.2.2. Enteral nutritional therapy
A nutritional therapy is an intervention which is intended to
improve or at least to sustain the nutritional status. Alternatively it
is used for the dietary treatment of a disease which requires a di-
etary intervention to protect the patients suffering from this dis-
ease, from complications or exacerbations.
Enteral nutrition is needed if patients suffer from a limited or
missing ability to meet their nutritional needs with normal or
modiﬁed or fortiﬁed food and if medical or nursing or other
nutritional support like counseling or food fortiﬁcation is notsufﬁcient to improve or sustain the situation of the patient. Ofﬁcial
and evaluated scientiﬁc and/or medical guidelines can help to
identify these patients.
Enteral nutrition and nutritional counseling as well as food
fortiﬁcation can be used together to complement the nutritional
composition of the patient's diet.
Before starting the therapy and whilst treating a patient the
nutritional status of the patient should be evaluated by adequate
methods. Therefore scientiﬁcally tested and evaluated tools like
Mini Nutritional Assessment (MNA®), Subjective Global Assess-
ment (SGA), Malnutrition Universal Screening Tool (MUST) or
Nutritional Risk Screening (NRS 2002) can be used. For pediatric
patients (children) percentile curves should be used. In Europe the
European society for clinical nutrition and metabolism (ESPEN)
D. Stippler et al. / Clinical Nutrition ESPEN 10 (2015) e219ee223e222recommends for hospitalized adult patients the use of the validated
NRS 2002 and for outpatients the MUST [15].
For patients suffering from rare inborn metabolic diseases,
which left untreated may develop into severe mental of physical
disturbances, a specially adopted nutritional therapy is essential.
For these patient groups the above mentioned malnutrition
assessment tools are not required.
2.2.3. Oral balanced diets
Oral balanced diets are food for special medical purposes ac-
cording to the EU directive intended for oral use. They are not
necessarily the sole source of nutrition. Oral balanced diets cover
mixtures of amino acids, further products especially adopted for
rare inborn respectively pediatric metabolic diseases, sip feedings,
powders for making sip feedings and liquids of higher viscosity.
2.2.3.1. Mixtures of amino acids and further products especially
adopted for rare inborn respectively pediatric metabolic diseases.
Mixtures of amino acids are foods for special medical purposes for
the dietary treatment of phenylketonuria (PKU) and other rare
inborn defects of the protein metabolism.
Further products especially formulated for rare inborn or pedi-
atric metabolic diseases are food for special medical purposes
especially formulated and modiﬁed for rare inborn defects of the
carbohydrate or lipid or energy metabolism (e.g. mitochondrial
diseases), cystic ﬁbrosis, epilepsy and further diseases where di-
etary management is a mandatory part of medical intervention.
2.2.3.2. Sip feedings, powders for making sip feedings and liquids of
higher viscosity. These products are food for special medical pur-
poses of different viscosity or powders (to produce the required
viscosity). They can be completely or supplementary balanced di-
ets. They are intended for oral ingestion and are used within a
nutritional therapy under medical supervision.
2.2.4. Tube feedings
Tube feedings are fully balanced food for special medical pur-
poses. They are intended to be given as a sole source of nutrition via
a tube. Tube feedings are liquids or powders to prepare liquid
nutrition.
2.2.5. Subcategories for sip e and tube feedings
2.2.5.1. Standard products. The composition of standard products is
dedicated to patients suffering from a missing or limited ability for
a normal nutrition. They are intended for a normal metabolism of
adult patients. Standard products can be used for most of the pa-
tients, who require tube or sip feeds.
Such an enteral standard product can be administered to all
patients who are not suffering from diseases which need to be
treated with special adopted products. One example for such a
disease is renal insufﬁciency.
2.2.5.2. Special products. Special products are especially formu-
lated and adopted for the dietary management of patients suffering
from a missing or limited ability for normal nutrition with an
additional metabolic demand (e.g. malabsorption). This subgroup is
called Special A. Furthermore there are some special products
which are intended for a direct dietary treatment of the underlying
disease (e.g. Crohn's disease) which are called Special B.
The metabolic demand is based on the nature of the underlying
disease. This results in a speciﬁc nutritional proﬁle of the products
and speciﬁc requests for the ingredients.
Examples for such adopted nutritional proﬁles are:
- Products adopted especially for infants and young children.- Products adopted for renal insufﬁciency.
- Products containing extensively hydrolyzed proteins or mix-
tures of amino acids for infants and young children suffering
from cow's milk allergy or patients suffering frommultiple food
allergies.
- Products containing hydrolyzed fats or carbohydrates or which
are especially enriched with middle chained triglycerides for
patients suffering from proven disturbances of the fat meta-
bolism or from digestion disorders for fatty acids (e.g. short
bowel syndrome).
3. Demarcation of food and pharmacological products
Food for special medical purposes currently belongs to the di-
etary food category. Food is traditionally divided into two cate-
gories e food for common use and dietary food. Based on the new
regulation on food for speciﬁc groups a dietary food category will
no longer be existent from 2016 on. Food for special medical pur-
posewill then belong to the category of food for special groups [16].
Dietary food is dedicated to people, who suffer from diseases or
disorders with special metabolic and nutritional demands. Dietary
food is not a pharmaceutical product but a special food category.
4. Discussion
This categorization system aims to summarize the deﬁnitions
and demands for FSMP products for enteral use for users. Based on
a system developed for Germany, it is intended to start the dis-
cussion with other contries, whether such a system is useful to
implement either in countries or EU wide. May be it has to be
adopted or changed for different countries but it can be a starting
point for this process.
5. Summary
The development of this new categorization system for food
for special medical purposes for enteral use was driven by two
main challenges. Firstly the upcoming changes in the German
social law which will affect reimbursement of the products.
Further many different and sometimes misleading deﬁnitions
which are used to describe enteral nutrition in the scientiﬁc and
legislative context. This new system incorporates the latest
published research and guidelines in the area of medical
nutrition.
The system was developed by an interdisciplinary working
group representing the German industrial associations and it was
introduced to the German scientiﬁc society. It was discussed within
the experts from the scientiﬁc ﬁeld and their feedback was
integrated.
This product categorization system consists of a table, which
brieﬂy describes the different kinds of products for enteral use and
their main composition. Additionally there is an explanation of the
currently used terms in the area of enteral nutrition. This system is
intended to support medical/health care professionals as well as
health insurance companies and other stakeholders.
The system and the categories reﬂect the practical application of
medical nutritional products as well as the current scientiﬁc
guidelines and the legal requirements. This should enable pre-
scribers of products to easily categorize the products and also
payers to carefully identify the rationale for receiving a product,
thus enabling products to be used securely and minimize uncer-
tainty associated sometimeswith their use. This should enable such
products to be used clearly and securely, thereby fulﬁlling their
legal requirements.
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